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Leptin is one of the adipocytokines produced from adi-
pose tissue but its functions in periodontal tissue have not 
previously been investigated. In our current study, we exa-
mined the effects of leptin on the expression of interleukin 
(IL)-6 and IL-8 in periodontal ligament (PDL) cells and 
gingival fibroblasts. Leptin receptor expression was evalua-
ted by RT-PCR and the production of cytokines was mea-
sured by ELISA. The phosphorylation of Akt and Erk1/2 
was assessed by western blotting. mRNA of long and short 
form leptin receptors were detected in both PDL cells and 
gingival fibroblasts. Leptin was found to increase the pro-
duction of IL-6 and IL-8 in both of these cell types, an 
effect which was not blocked by polymyxin B, an inhibitor 
of lipopolysaccharide (LPS). Leptin did not alter the pro-
duction of IL-6 and IL-8 induced by LPS in PDL cells but 
increased Akt and Erk1/2 phosphorylation in these cells. 
These results suggest that leptin acts as an inducer of IL-6 
and IL-8 in PDL cells and gingival fibroblasts.
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Introduction
Leptin is one of the adipokines produced from adipocytes 
[1]. Leptin is encoded by the gene obese (ob), and its cir-
culating levels are correlated with white adipose tissue mass 
[1,2]. Leptin decreases food intake and increases energy con-
sumption by inducing anorexigenic factors. Additionally, 
leptin behaves as a mediator of inflammation in monocytes/ 
macrophages and neutrophils [2]. Leptin stimulates prolife-
ration, phagocytosis, and expression of cytokines and enzymes 
such as interleukin (IL)-1, IL-6, tumor necrosis factor (TNF), 
nitric oxide synthase, and cyclooxygenase-2 in monocytes/ 
macrophages. Leptin also increases chemotaxis and hyd-
rogen peroxide production in neutrophils. Leptin receptors 
are encoded by the gene diabetes (db), and multiple receptor 
isoforms result from alternative splicing of the db gene 
[1-4]. Among the isoforms, the long form of leptin receptor has 
a cytoplasmic domain with Janus kinase binding sites and 
plays a pivotal role mediating leptin signaling. 
Periodontitis is an inflammatory disease caused by bac-
teria or an immune reaction against bacteria [5,6]. Previous 
studies have demonstrated the relationship between perio-
dontitis and leptin levels. Leptin concentration decreases in 
gingival crevicular fluid (GCF), but increases in serum, 
depending on the severity of periodontal destruction [7-9]. 
Elevated serum leptin level in periodontitis is associated 
with acute myocardial infarction, suggesting that the inc-
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rease in serum leptin in patients with periodontitis acce-
lerates the inflammatory process in arteriosclerotic lesions 
and increases the risk for acute myocardial infarction [10]. 
Although studies have suggested that the higher concentra-
tion of leptin in GCF may play a protective role in perio-
dontal tissue, the mechanism underlying the change in leptin 
level or the function of leptin has not been investigated in 
periodontal tissue. The effect of leptin on periodontal liga-
ment (PDL) cells and gingival fibroblasts has not been 
determined, but it was reported recently that leptin and the 
leptin receptor affect function of fibroblasts in synovium 
and dermis [11,12]. PDL cells and gingival fibroblasts 
mainly consist of periodontal tissue and play an important 
role producing pro-inflammatory cytokines in periodontal 
tissue [13]. IL-6 is closely related with the recruitment of T 
cells and acts as a T and B cell differentiation factor [14]. 
IL-8 stimulates the expression of adhesion molecules 
(CD11/18), the migration, and the release of enzyme and 
reactive oxygen intermediates in neutrophils [15]. Therefore, 
to investigate the function of leptin in periodontal tissue, we 
assessed leptin receptor expression and the effect of leptin 
on expression of pro-inflammatory cytokines such as IL-6 
and IL-8 in PDL cells and gingival fibroblasts. 
Material and Methods 
Cell cultures
PDL or gingival fibroblast cells were prepared from teeth 
extracted for orthodontic treatment or from gingival tissue. 
This protocol was approved by the Institutional Review 
Board of Yonsei Dental Hospital (IRB No. 2-2010-0005). 
PDL tissue fragments were removed from the middle one- third 
of the extracted tooth roots and were washed three times 
with α-modified Eagle’s medium (α-MEM; Gibco BRL, 
Rockville, MD, USA) containing 300 mg/ml streptomycin, 
300 unit/ml penicillin, and 0.75 mg/ml amphotericin-B (Gibco 
BRL). PDL tissue fragments were placed in 100 mm dishes 
containing α-MEM supplemented with 100 mg/ml strep-
tomycin, 100 unit/ml penicillin, 0.25 mg/ml amphoteri-
cin-B, and 20% fetal bovine serum (FBS, Gibco BRL). The 
culture media were replaced every 2 days until cells grew from 
the fragments, and then the cultures were maintained with α
-MEM containing antibiotics and 10% FBS. Upon reaching 
70% confluence, the cells were removed with 0.25% trypsin 
and passaged to 100 mm dishes. Gingival fibroblasts were 
prepared from gingival tissues excised for crown lengthe-
ning. Gingival tissues were cut into small fragments and then the 
tissue fragments were incubated in 2.4 U dispase II (Roche, 
Mannheim, Germany) and 0.25% collagenase (Roche) for 1 
h at 37°C. The tissue fragments were then separated into 
epithelial and connective tissues. Connective tissue frag-
ments were placed in 100 mm dishes containing Dulbecco's 
Modified Eagle's Medium (Gibco BRL) supplemented with 
antibiotics and 10% FBS and were cultured according to the 
same procedure as the PDL cells. THP-1 monocytes were 
maintained in Roswell Park Memorial Institute medium 
(Gibco BRL) 1640 containing antibiotics and 10% FBS.
Reverse transcription-polymerase chain reaction (RT-PCR)
PDL cells or gingival fibroblasts (5 × 105 cells/well) were 
cultured in 6 well plates. THP-1 monocytes (5 × 105 cells/ 
well) were plated in 6 well culture plates and treated with phor-
bol myristic acid (100 ng/ml, Sigma, St. Louis, USA) for 24 h 
to induce differentiation of monocytes into macrophages. Total 
RNA in adipose tissue from the inguinal region, PDL cells, 
gingival fibroblasts, or THP-1 macrophages was isolated 
with Trizol reagent (Invitrogen, Carlsbad, CA, USA). Two µg 
of total RNA was converted to cDNA using an RT Premix kit 
(Bioneer, Seoul, Korea) in accordance with the manufactu-
rer’s instructions. The cDNA population was amplified with 
i-StarTaq (Intron Biotech, Seongnam, Korea) and compared 
with the concurrently measured GAPDH expression level. For 
semi quantitative RT-PCR, two concentrations of the cDNA 
template were amplified to determine the optimal cDNA 
amounts. In addition, several PCR cycles were tested to deter-
mine the range in which amplification was in the exponen-
tial phase. The PCR products were then resolved by electro-
phoresis on 1% agarose gels containing ethidium bromide. 
The primers, annealing temperatures and the optimized PCR 
cycle number are given in Table 1 [16,17].
Measurement of IL-6 and IL-8 production by enzyme- 
linked immunosorbent assay (ELISA)
PDL cells or gingival fibroblasts (1.7 × 105 cells/well) 
were plated in 24 well culture plates and maintained in 
media containing antibiotics and 10% FBS for 7 h. After the 
indicated time, the cells were starved in serum-free media 
for 20 h. Then, the cells were treated with human recom-
binant leptin (R&D Systems, Minneapolis, MN, USA) or 
LPS (Sigma Chemical Co., St. Louis, Mo, USA) for 24 h. 
The cells were pretreated with polymyxin B (Sigma) for 1 h 
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Table 1. PCR primer sequences
Gene Primer sequence (5'‐3') Product length (bp) Annealing Tm. (°C) Cycles
Leptin F : TTCACACACGCAGTCAGTCTCCR : ACAGAGTCCTGGATAAGGGGTG 348 60 28
Leptin receptor Long form F : CAGAAGCCAGAAACGTTTGAGR : AGCCCTTGTTCTTCACCAGT 344 52 35
Short form 219.1 F : TTGGAAGCCCCTGATGAAA 



















and then treated with leptin or LPS for 24 h. The PDL cells 
were treated with LPS in the absence or presence of leptin 
for 24 h to estimate the effect of leptin on LPS-induced cyto-
kine expression. After treatment, the level of IL-6 or IL-8 was 
measured in the culture supernatants from cells using a com-
mercially available ELISA kit (BioLegend, San Diego, CA, 
USA) in accordance with the manufacturer’s instructions.
Cell viability assay
Cell viability was measured using the 3-(4,5-dimethyl-
thiazol-2-yl)2,5-diphenyl tetrazolium bromide (MTT) assay. 
PDL cells or gingival fibroblasts (1.7 × 105 cells/well) were 
seeded in 24 well plates and maintained in media containing 
antibiotics and 10% FBS. After 7 h, the cells were starved in 
serum-free media for 20 h and then treated with the indi-
cated concentrations of polymyxin B for 24 h. After treat-
ment, 20 µl of MTT solution (5 mg/ml in PBS, Sigma) was 
added to each well. After a 4 h incubation, the media were 
aspirated, and 200 µl of dimethylsulfoxide (Sigma) was added 
to each well to dissolve the MTT-formazan crystals. The 
absorbance was measured with an MRX II microplate reader 
(Dynatech Labs, Chantilly, VA, USA) at 570 nm.
Western blotting
PDL cells (5 × 105 cells/well) were cultured in 6 well plates 
and maintained in media containing antibiotics and 10% 
FBS for the protein analysis. After 7 h, the cells were 
starved in serum-free media for 20 h and then treated with 
10 µg/ml leptin for the indicated time intervals. Then whole 
cells were lysed in 1× lysis buffer [20 mM Tris-HCl (pH 
7.5), 150 mM NaCl, 1 mM Na2EDTA, 1% Triton, 2.5 mM 
sodium pyrophosphate, 1 mM β-glycerophosphate, 1 mM 
Na3VO4, 1 µg/ml leupeptin, and 1 mM PMSF; Cell Sig-
naling Technology, Danvers, MA, USA]. After centrifu-
gation, the supernatant was used for the protein assay. 
Protein concentrations were determined with the BSA Pro-
tein Assay kit (Bio-Rad, Hercules, CA, USA). Forty µg of 
protein was electrophoresed on 10% SDS-polyacrylamide 
gel. The electrophoretically separated proteins were electro- 
blotted onto PVDF membranes (Bio-Rad). The membranes 
were blocked with 5% BSA in Tris buffer saline (10 mM 
Tris-HCl, 166 mM NaCl, pH 7.4). The primary antibodies 
were anti-phospho-Akt (Cell Signaling Technology), anti- 
phospho-Erk1/2 (Cell Signaling Technology), anti-Akt (Cell 
Signaling Technology), or anti-Erk1/2 (Cell Signaling Tech-
nology) and were diluted at 1:1000, respectively. Peroxi-
dase-conjugated anti-rabbit antibody (Jackson Immuno 
Research, West Grove, PA, USA) was used at 1:2500 as the se-
condary antibody. Protein bands were visualized with an ECL 
kit (Amersham Bioscience, Buckinghamshire, UK). Band 
intensity was measured using Spot Denso Analysis of FROG 
2000 software (Alpha Innotech, San Leandro, CA, USA).
Statistical analysis 
Results were analyzed using one-way analysis of variance 
and Tukey’s test (SPSS Inc., Chicago, IL, USA). A p value 
< 0.05 was considered significant. 
Results
Expression of leptin and leptin receptors
To observe the expression of leptin and leptin receptors in 
periodontal tissue, the expression in PDL cells and gingival 
fibroblasts was estimated by RT-PCR. Leptin was expressed 
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Fig. 1. Expression of leptin and leptin receptors in periodontal 
ligament (PDL) cells and gingival fibroblasts. Expression of 
leptin was assessed by RT-PCR in adipose tissue, PDL cells, 
and gingival fibroblasts (GF) (A). Expression of leptin rece-
ptors was estimated by RT-PCR in PDL cells, GF, and THP-1 
macrophages (B).
in adipose tissues isolated from subcutaneous tissue in the 
inguinal region, but was not expressed in PDL cells or 
gingival fibroblasts (Fig. 1A). Long and short forms of the 
leptin receptor were expressed in PDL cells, gingival fibro-
blasts, and THP-1 macrophages (Fig. 1B). In leptin recep-
tors of gingival fibroblasts and THP-1 macrophages, expres-
sion level of short form 219.2 was lower than that of PDL 
cells and other short forms (291.1 and 291.3).
Effect of leptin on IL-6 and IL-8 expression
To observe whether leptin acts as an inducer of cytokines 
in periodontal tissue, IL-6 and IL-8 protein levels in culture 
supernatants of PDL cells and gingival fibroblasts treated 
with leptin were estimated by ELISA. Leptin treatment inc-
reased IL-6 and IL-8 expression in PDL cells (Fig. 2A and 
2B white bar). When compared to those of untreated PDL 
cells, IL-6 expression significantly increased at a concen-
tration of 10 µg/ml leptin (Fig. 2A white bar). IL-8 expres-
sion increased in a dose dependent manner (Fig. 2B whi-
tebar). The expression of IL-6 and IL-8 in gingival fibrob-
lasts was also induced similar to that in PDL cells (Fig. 2A 
and 2B black bar). That is, IL-6 expression increased 
significantly in a dose-dependent manner and IL-8 expres-
sion was significantly elevated at a concentration of 10 µ
g/ml as compared to untreated cells.
To confirm the effect of leptin on cytokine expression, 
Fig. 2. Effect of leptin on IL-6 and IL-8 production PDL cells 
and gingival fibroblasts. PDL cells and gingival fibroblasts 
(GF) were cultured for 24 h in the presence of either media 
alone or the indicated concentrations of leptin. Levels of IL-6 
(A) and IL-8 (B) in culture supernatants were assayed ELISA. 
*Significant difference (p<0.05) compared to untreated cells.
PDL cells and gingival fibroblasts were treated with leptin in 
the presence of polymyxin B (100 µg/ml), an inhibitor of LPS. 
LPS increased IL-6 and IL-8 expression in both cell types 
(Fig. 3B and 3C left panel). Polymyxin B inhibited LPS- 
induced IL-6 and IL-8 expression (Fig. 3B and 3C left 
panel), but did not inhibit leptin-induced IL-6 and IL-8 expres-
sion in PDL cells and gingival fibroblasts (Fig. 3B and 3C 
right panel). The results of MTT assay in both cell types 
demonstrated that polymyxin B did not exert inhibitory 
effects on cell viability up to 500 µg/ml (Fig. 3A).
Effect of leptin on LPS-induced IL-6 and IL-8 expression
To observe the effect of leptin on IL-6 and IL-8 expres-
sion induced by LPS, PDL cells were treated with leptin in 
the presence of suboptimal dose of LPS and then the levels 
of cytokines in culture supernatants were estimated by ELISA. 
When PDL cells were treated with 2 and 5 ng/ml LPS, IL-6 
and IL-8 expression increased in a dose-dependent manner (Fig. 
4). When the PDL cells were treated with leptin in the presence 
or absence of 2 ng/ml LPS, LPS and leptin combination trea-
ted cells showed an increase tendency of IL-6 and IL-8 expres-
sion compared to LPS-treated cells, but it was not significant.
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Fig. 3. Effect of polymyxin B (poly B) on leptin-induced cytokine expression of PDL cells and gingival fibroblasts. PDL cells and 
gingival fibroblasts (GF) were treated with poly B for 24 h and cell viability was estimated by the MTT assay (A). Cells were 
cultured for 24 h in the presence of either media alone, leptin (10 µg/ml), or LPS (100 ng/ml) in the presence or absence of poly B 
(100 µg/ml). Levels of IL-6 (B) and IL-8 (C) in culture supernatants were assayed by ELISA. *Significant difference (p<0.05) 
compared to untreated cells. # Significant difference (p<0.05) compared to LPS-treated cells.
Expression of phosphorylated Akt and Erk1/2 
Phosphorylation of Akt and Erk1/2 was estimated in leptin- 
treated PDL cells by western blot. As shown in Fig. 5, Akt 
phosphorylation increased at 15 min after leptin treatment, 
but it decreased gradually at 30 and 60 min. The Erk1/2 phos-
phorylation expression pattern was similar to that of Akt.
Discussion
Leptin is mainly produced from adipocytes [18] and in 
minor quantities in placenta [19], gastric mucosa [20], T 
cells [21], and osteoblasts [22]. In addition, dermal fibro
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Fig. 5. Phosphorylation of Akt and Erk1/2 in leptin-treated PDL cells. PDL cells were cultured in the absence or presence of leptin 
(10 µg/ml) for the indicated times. Cell lysates were subjected to immunoblot analysis with antibodies recognizing the 
phosphorylated Akt or Erk1/2 and with antibody recognizing total Akt or Erk1/2 as loading controls (A). The phosphorylation value 
at 0 min was set to 1 to allow comparison with the relative phosphorylation levels at subsequent time-points (B).
Fig. 4. Effect of leptin on LPS-induced cytokine expression of 
PDL cells. PDL cells were cultured for 24 h in the presence of leptin 
(10 µg/ml) or/and LPS (2 and 5 ng/ml) and levels of IL-6 (A) and 
IL-8 (B) in culture supernatants were assayed by ELISA. *Sig-
nificant difference (p<0.05) compared to untreated cells.
blasts also express leptin and leptin receptors, suggesting that 
leptin produced from fibroblasts, may exert local autocrine 
and paracrine actions and contribute to the plasma levels of 
leptin [23]. PDL cells and gingival fibroblasts are repre-
sentative cells in periodontal tissues. Therefore, we exa-
mined whether leptin and leptin receptors are expressed in 
PDL cells and gingival fibroblasts. Adipose tissue expressed 
leptin mRNA, but PDL cells and gingival fibroblasts did not 
express leptin mRNA. This indicates that PDL cells and 
gingival fibroblasts are not a source of leptin in periodontal 
tissue. PDL cells and gingival fibroblasts expressed the long 
and short forms of the leptin receptor similar to expression 
in THP-1 macrophages which express both the long and 
short forms of the leptin receptor [24]. Among the leptin 
receptors of gingival fibroblasts, expression of the short 
form 219.2 was weaker than that of other short forms. This 
pattern is similar to dermal fibroblasts and adrenal tissue 
[16,23]. Among the leptin receptors, long form is known to 
transduce the activation signal [1,4]. Taken together, it is 
considered that leptin may affect the function of PDL cells 
and gingival fibroblasts via long form of leptin receptor. 
Leptin acts as a stimulator of cytokines such as IL-1, 
IL-6, IL-8, and TNF in various cells including monocytes, 
macrophages, and synovial fibroblasts [1,11,24,25]. In this 
study, leptin increased IL-6 and IL-8 expression in PDL cells 
and gingival fibroblasts. Because leptin used in this study 
was are recombinant protein, we treated PDL cell and 
gingival fibroblasts with leptin in the presence of polymyxin 
B, an inhibitor of LPS to rule out the activity of conta-
minated LPS. Polymyxin B inhibited LPS-induced IL-6 and 
IL-8 expression, but did not block the IL-6 and IL-8 exp-
ression induced by leptin in both cells. These results 
indicate that leptin acts as an inducer of IL-6 and IL-8 in 
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PDL cells and gingival fibroblasts. In other study using PDL 
cells and gingival fibroblasts from same donor, concen-
tration of LPS which began to increase IL-6 expression was 
different between PDL cells and gingival fibroblasts, sug-
gesting that PDL cells and gingival fibroblasts have a dif-
ferent ability to produce IL-6 [26]. Similar to the response to 
LPS, concentration of leptin which increased the expression 
of cytokines was different between PDL cells and gingival 
fibroblasts. However, we did not compare response of PDL 
cells and gingival fibroblasts cultured from same donor. 
Therefore, it will be needed to confirm the different response 
of both cells from same donor. 
In macrophages, leptin treatment not only induced TNF and 
IL-8 production, but also enhanced LPS-induced TNF pro-
duction. However it did not alter LPS-induced IL-8 produc-
tion [24]. Most representative periodontopathogens are gram 
negative bacteria containing LPS. Therefore, we also obser-
ved the effect of leptin on cytokine expression induced by 
suboptimal dose of LPS in PDL cells. LPS increased the 
expression of IL-6 and IL-8 in PDL cells, but leptin did not 
change the expression of these cytokines induced by LPS. 
This indicates that leptin cannot potentiate LPS-induced IL-6 
and IL-8 expression in both cells. 
The leptin-signaling pathways are closely related with STAT 
signaling pathway, MAPK signaling pathway, and Erk sig-
naling pathway [3]. In this study, leptin-treated PDL cells 
showed increased activation of Akt and Erk1/2 as eosinop-
hils, synovial fibroblasts, and adipose tissue activated by 
leptin [11,27,28]. These results suggest that Akt and Erk1/2 
may be involved in IL-6 and IL-8 expression.
Patients with rheumatoid arthritis display increased circu-
lating leptin levels in comparison with a healthy group [29]. 
Leptin expression in cartilage of patients with osteoarthritis 
is higher than that in a normal group [30]. Leptin increases 
IL-8 production in synovial fibroblasts cultured from pat-
ients with rheumatoid arthritis and osteoarthritis [11]. These 
studies suggest that leptin plays an important role in inflam-
mation such as rheumatoid arthritis and osteoarthritis. We 
found that leptin acts as pro-inflammatory cytokine in pe-
riodontal tissue through induction of IL-6 and IL-8 in PDL 
cells and gingival fibroblasts. In contrast to the leptin level 
in cartilage tissue of patients with osteoarthritis, the leptin 
level in GC and gingival tissues in patients with perio-
dontitis is lower than that in a healthy group [7-9,31]. In the 
future, in vivo study will be necessary to determine whether 
the pro-inflammatory effect of leptin is beneficial or detri-
mental to periodontal tissue. 
In this study, we first showed that leptin receptors are 
expressed in PDL cells and gingival fibroblasts and that 
leptin acts as an inducer of IL-6 and IL-8 in both cell types. 
These results suggest that leptin affects induction of pro- 
inflammatory cytokines in periodontal tissue. 
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